MDR is usually triggered by the overexpression of ATP-binding cassette transporters (ABC transporters) such as P-glycoprotein (P-gp), which actively expel chemotherapeutic drugs from tumor cells, thus making the drug concentration insufficient for therapeutic effects [95]. The gene discussed is ABCG2; the disease is neoplasm.